Compare AMRX & HP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMRX | HP |
|---|---|---|
| Founded | 2002 | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.7B |
| IPO Year | 2018 | 1994 |
| Metric | AMRX | HP |
|---|---|---|
| Price | $13.41 | $41.55 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 12 |
| Target Price | $15.60 | ★ $34.17 |
| AVG Volume (30 Days) | ★ 1.4M | 968.7K |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.44% |
| EPS Growth | ★ 157.89 | N/A |
| EPS | ★ 0.22 | N/A |
| Revenue | N/A | ★ $3,746,013,000.00 |
| Revenue This Year | $4.48 | $9.50 |
| Revenue Next Year | $7.13 | $3.34 |
| P/E Ratio | $59.44 | ★ N/A |
| Revenue Growth | N/A | ★ 35.89 |
| 52 Week Low | $7.02 | $14.65 |
| 52 Week High | $15.42 | $41.14 |
| Indicator | AMRX | HP |
|---|---|---|
| Relative Strength Index (RSI) | 60.20 | 71.20 |
| Support Level | $12.45 | $32.88 |
| Resistance Level | $13.54 | N/A |
| Average True Range (ATR) | 0.51 | 1.24 |
| MACD | 0.05 | 0.53 |
| Stochastic Oscillator | 69.21 | 97.54 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Helmerich & Payne Inc provides performance-driven drilling solutions and technologies to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. Focusing on the drilling segment, its technology services develop and commercialize solutions that improve drilling efficiency, accuracy, and wellbore quality and placement. The company operates through North America Solutions, International Solutions, and Offshore Solutions segments. The North America segment runs a technologically advanced AC drive drilling rig fleet in the U.S., with a presence in shale and unconventional basins, while the Offshore Solutions segment, operating rigs on fixed-leg and floating platforms, generates the majority of revenue.